GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Enzymotec Ltd (NAS:ENZY) » Definitions » Gross Margin %

Enzymotec (Enzymotec) Gross Margin % : 69.53% (As of Sep. 2017)


View and export this data going back to 2013. Start your Free Trial

What is Enzymotec Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Enzymotec's Gross Profit for the three months ended in Sep. 2017 was $9.51 Mil. Enzymotec's Revenue for the three months ended in Sep. 2017 was $13.67 Mil. Therefore, Enzymotec's Gross Margin % for the quarter that ended in Sep. 2017 was 69.53%.


The historical rank and industry rank for Enzymotec's Gross Margin % or its related term are showing as below:


ENZY's Gross Margin % is not ranked *
in the Biotechnology industry.
Industry Median: 59.655
* Ranked among companies with meaningful Gross Margin % only.

Enzymotec had a gross margin of 69.53% for the quarter that ended in Sep. 2017 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Enzymotec was 0.00% per year.


Enzymotec Gross Margin % Historical Data

The historical data trend for Enzymotec's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzymotec Gross Margin % Chart

Enzymotec Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Gross Margin %
Get a 7-Day Free Trial 47.67 50.58 61.12 61.03 62.87

Enzymotec Quarterly Data
Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 66.03 46.38 70.20 50.24 69.53

Competitive Comparison of Enzymotec's Gross Margin %

For the Biotechnology subindustry, Enzymotec's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enzymotec's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Enzymotec's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Enzymotec's Gross Margin % falls into.



Enzymotec Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Enzymotec's Gross Margin for the fiscal year that ended in Dec. 2016 is calculated as

Gross Margin % (A: Dec. 2016 )=Gross Profit (A: Dec. 2016 ) / Revenue (A: Dec. 2016 )
=30 / 47.696
=(Revenue - Cost of Goods Sold) / Revenue
=(47.696 - 17.709) / 47.696
=62.87 %

Enzymotec's Gross Margin for the quarter that ended in Sep. 2017 is calculated as


Gross Margin % (Q: Sep. 2017 )=Gross Profit (Q: Sep. 2017 ) / Revenue (Q: Sep. 2017 )
=9.5 / 13.672
=(Revenue - Cost of Goods Sold) / Revenue
=(13.672 - 4.166) / 13.672
=69.53 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Enzymotec  (NAS:ENZY) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Enzymotec had a gross margin of 69.53% for the quarter that ended in Sep. 2017 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Enzymotec Gross Margin % Related Terms

Thank you for viewing the detailed overview of Enzymotec's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Enzymotec (Enzymotec) Business Description

Traded in Other Exchanges
N/A
Address
Enzymotec Ltd is nutritional and food ingredients company. It develops and manufactures nutritional ingredients and medical foods based on proprietary technologies. Its product portfolio includes Infat, K-Real, Enzy PS solutions, Vayacog, Vayarin and Vayaroll. The company has Nutrition and Vaya Pharma reportable segments. It derives majority of its revenues from Nutrition segment. The firm mainly operates in America, Europe, Australia, Asia, and Israel.

Enzymotec (Enzymotec) Headlines

From GuruFocus

Tiger Management Founder Julian Robertson Ups Stake in Enzymotec

By Kyle Ferguson Kyle Ferguson 12-07-2015

Julian Robertson Cuts Half of Stake in Paulson-Backed Company

By Holly LaFon Holly LaFon 07-01-2016

Julian Robertson Adds to Multiple Positions in 3rd quarter

By Tiziano Frateschi Tiziano Frateschi 12-20-2016